Key Metrics
Journal Specifications
- PublisherKARGER
- LanguageEnglish
- FrequencyBi-monthly
- LanguageEnglish
- FrequencyBi-monthly
- Publication Start Year1990
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Pathobiology been publishing? 
The Pathobiology has been publishing since 1990 till date.
How frequently is the Pathobiology published? 
Pathobiology is published Bi-monthly.
Who is the publisher of Pathobiology? 
The publisher of Pathobiology is KARGER.
How can I view the journal metrics of Pathobiology on editage? 
For the Pathobiology metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Pathobiology? 
The eISSN number is 1423-0291 and pISSN number is 1015-2008 for Pathobiology.
What is the focus of this journal? 
The journal covers a wide range of topics inlcuding Lung cancer, Cancer development, Type 2 Diabetes Mellitus, Pleuropulmonary blastoma, Immunohistochemistry, Cause of death, Breast cancer, Pulmonary embolism, Saliva, Tumor microenvironment, Oral Microbiota, Carcinogenesis, Colorectal cancer, Acute respiratory distress, Human body, Lymphoma, Cervical cancer, Vascular smooth muscle, Salivary Gland Tissue, Dysbiosis.
Why is it important to find the right journal for my research? 
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career? 
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only? 
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.